Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies
深入了解 serplulimab 的作用机制:一种独特的抗 PD-1 单克隆抗体,与 TIGIT 或 LAG3 抑制剂联合用于临床前肿瘤免疫治疗研究
期刊:MAbs
影响因子:5.6
doi:10.1080/19420862.2024.2419838
Yizhou Zhang, Ruicheng Wei, Ge Song, Xinyi Yang, Mengli Zhang, Wei Liu, Aiying Xiong, Xuehan Zhang, Qianhao Li, Wan-Jen Yang, Chencheng Han, Rui Liu, Chen Hu, Qingyu Wang, Jun Zhu, Yongqiang Shan